Patients with early stages of Parkinson’s disease (PD) exhibit arrhythmic expression of circadian genes, impaired blood levels of cortisol and melatonin, impaired sleep quality, and decreased BMAL1 mRNA levels in whole blood white cells, which is associated with the severity of PD symptoms [46]. Here, BMAL1 is linked to Parkinson disease.